Vagus nerve stimulation for intractable epilepsy in children

Developmental Medicine and Child Neurology

Volumn 42, Issue 7, 2000, Pages 496-499

  Labar, Douglas ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; FELBAMATE; LAMOTRIGINE; TOPIRAMATE;

AFFECTIVE NEUROSIS; ANEMIA; APNEA; ARTICLE; BEHAVIOR DISORDER; BENIGN CHILDHOOD EPILEPSY; BODY WEIGHT DISORDER; CHILD; CLINICAL TRIAL; COMPLICATION; DIPLOPIA; DOUBLE BLIND PROCEDURE; FATIGUE; HAIR LOSS; HEADACHE; HUMAN; IMPLANTATION; INTRACTABLE EPILEPSY; LENNOX GASTAUT SYNDROME; OUTCOMES RESEARCH; PRIORITY JOURNAL; PULSE GENERATOR; QUALITY OF LIFE; RASH; SAFETY; SLEEP DISORDER; SOMNOLENCE; VAGUS NERVE STIMULATION; VERTIGO; VOMITING;

ADOLESCENT; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; CLINICAL TRIALS; ELECTRIC STIMULATION THERAPY; EPILEPSY; FEMALE; HUMANS; INFANT; MALE; TREATMENT OUTCOME; VAGUS NERVE;

EID: 0033934912     PISSN: 00121622     EISSN: None     Source Type: Journal    
DOI: 10.1017/S001216220000092X     Document Type: Article

References (28)

1. Handforth A, DeGiorgio C, Schachter S, Uthman B, Naritoku D, Tecoma E, Henry T, Collins S, Vaughn B, Gilmartin R, et al. (1998) VNS therapy for partial onset seizures. Neurology 51: 48-55.
2. Salinsky M, George R, Sonnen A, Upton A, Ristanovic R, Bergen D, Mirza W, Rosenfeld W, Naritoku D, Manon-Espaillat R, et al. (1995) A randomized controlled trial of chronic VNS for treatment of medically intractable seizures. Neurology 45: 224-30.
3. Morris G, Mueller W, Andriola M, Ben-Menachem E, Casey K, Collins S, DeGiorgio C, Handforth A, Henry T, Kramer R, et al. (1999) Long-term treatment with VNS in patients with refractory epilepsy. Neurology 53: 1731-5.
4. McLachlan R. (1997) VNS for intractable epilepsy: a review. Journal of Clinical Neurophysiology 14: 358-68.
5. Schachter S, Saper C. (1998) Progress in epilepsy research: VNS. Epilepsia 39: 677-86.
6. Murphy J, Hornig G, Schallert G. (1995) Left VNS in children with refractory epilepsy. Archives of Neurology 52:886-9.
7. Hornig G, Murphy J, Schallert G, Tilton C. (1997) Left VNS in children with refractory epilepsy: an update. Southern Medical Journal 90: 484-8.
8. Murphy J, Andriola M, Barron T, Burgerman R, George R, Gilmartin R, Helmers S, Labar D, Labiner D, Manon-Espaillat R, et al. (1999) Left VNS: experience in 60 children with pharmacoresistant epilepsy. Journal of Pediatrics 134: 563-6.
9. Parker A, Polkey C, Binnie C, Madigan C, Ferrie C, Robinson R. (1999) VNS in epileptic encephalopathies. Pediatrics 103: 778-82.
10. Lundgren J, Amark P, Blennow G, Stromblad L, Wallstedt L. (1998) VNS in 16 children with refractory epilepsy. Epilepsia 39: 809-13.
11. Wheless J, Helmers S, Frost M, Gates J, Levisohn P, Tardo C, Conry J, Venkataraman V, Vaisleib I. (1999) VNS in children: efficacy. Epilepsia 40: (Suppl.) 120-1.
12. Schallert G, Foster J, Lindquist N, Murphy J. (1998) Chronic stimulation of the left vagal nerve in children: effect on swallowing. Epilepsia 39: 113-14.
13. Lundgren J, Ekberg O, Olsson R. (1998) Aspiration: a potential complication to VNS. Epilepsia 39: 998-1000.
14. Labar D, Murphy J, Tecoma E, Sala D, Burgerman R, Gilmartin R, Mirza W, Ney G, Osorio I, Salinsky M. (1999) VNS for generalized epilepsy. Neurology 52: 1510-12.
15. Murphy J, Hornig G, Schallert G, Tilton C. (1998) Adverse events in children receiving intermittent left VNS. Pediatric Neurology 19: 42-4.
16. Labar D, Nikolov B, Tarver B, Fraser R. (1998) VNS for symptomatic generalized epilepsy. Epilepsia 39: 201-5.
17. Ben-Menachem E, Hellstrom K, Waldton C, Augustinsson L. (1999) Evaluation of refractory epilepsy treated with VNS for up to 5 years. Neurology 52: 1265-7.
18. Ritter F, Leppik I, Dreifus F, Santilli N, Humzie R, Dodson W, Glauser T, Sackellares C, Olsen L, Garafalo E, et al. (1993) Efficacy of felbamate in childhood epileptic encephalopthy (LGS). New England Journal of Medicine 328: 29-33.
19. French J, Smith M, Faught E, Brown L. (1999) The use of felbamate in the treatment of patients with intractable epilepsy. Neurology 52: 1540-5.
20. Gates J, Wada J, Reeves A, Lassone M, Papo I, Spenser S, Andermann F, Risse G, Ritter R, Purves S. (1993) Reevaluation of corpus callosotomy In: Engel J, editor. Surgical Treatment of the Epilepsies. New York: Raven Press, p 637-48.
21. Behrens E, Schramm J, Zenter J, Konig R. (1997) Surgical and neurological complications in a series of 708 epilepsy surgery procedures. Neurosurgery 41: 1-10.
22. Vickrey B, Hays R, Rausch R, Engel J, Visscher B, Ary C, Rogers W, Brock R. (1995) Outcomes in 248 patients who had diagnostic evaluations for epilepsy surgery. Lancet 346: 1445-9.
23. Annegers J, Coan S, Hauser W, Leestma J, Duffell W, Tarver. (1998) Epilepsy, VNS by the NCP system, mortality, and sudden, unexpected death. Epilepsia 39: 206-12.
24. Donaldson J, Glauser R, Olberding L. (1997) LTG adjunctive therapy in the LGS. Epilepsia 38: 68-73.
25. Eriksson A, Nergardh A, Hoppu K. (1998) The efficacy of LTG in children and adolescents with refractory generalized epilepsy: a randomized, double-blind crossover study. Epilepsia 39: 495-501.
26. Motte J, Trevathan E. Arvidsson I, Barrera M, Mullens E, Manasco P, Dulac O, Mai J, Billard C, Valle L, et al. (1991) LTG for generalized seizures associated with the LGS. New England Journal of Medicine 337: 1807-12.
27. Guberman A, Besag F, Brodie M. Dooley J, Duchowny M, Pellock J, Richens A, Stern R, Trevathan E. (1999) LTG-associated rash: risk/benefit considerations in adults and children. Epilepsia 40: 985-91.
28. Sachdeo R, Blauser T, Ritter F, Reife R, Lim P, Pledger G, Crumrine P, Ferreira J, French J, Glauser T. et al. (1999) A double-blind, randomized trial of TPM in LGS. Neurology 52: 1882-7.